연구
교육
솔루션
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
The Ph.D. Program for Neural Regenerative Medicine,
College of Medical Science and Technology,
The Ph.D. Program for Neural Regenerative Medicine, College of Medical Science and Technology
Reni Ajoy has not added Biography.
If you are Reni Ajoy and would like to personalize this page please email our Author Liaison for assistance.
CCL5/RANTES contributes to hypothalamic insulin signaling for systemic insulin responsiveness through CCR5.
Scientific reports Nov, 2016 | Pubmed ID: 27898058
Taipei Medical University and National Health Research
Taipei Medical University
Chun Austin Changou1,2,3,
Reni Ajoy4,5,
Szu-Yi Chou4,5,6
1The Ph.D. Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University,
2Integrated Laboratory, Center of Translational Medicine, Taipei Medical University,
3Core Facility, Taipei Medical University,
4The Ph.D. Program for Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University,
5Graduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University,
6TMU research center for Neurotrauma and Neuroregeneration, College of Medical Science and Technology, Taipei Medical University
Reni Ajoy1,2,
Szu-Yi Chou1,2,3
1The Ph.D. Program for Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University and National Health Research,
2Graduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University,
3TMU research center for Neurotrauma and Neuroregeneration, College of Medical Science and Technology, Taipei Medical University
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유